Repare Therapeutics Inc. (RPTX) Tops Q3 EPS by 41c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q3 EPS of ($0.45), $0.41 better than the analyst estimate of ($0.86). Revenue for the quarter came in at $2.16 million versus the consensus estimate of $6.31 million.

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c